AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Voglow 0.3 GM1 Tablet

Prescription Icon
Prescription Required

Marketer

Primus Remedies Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.3mg)

Overview Voglow 0.3 GM1 Tablet

Diabetics using the anti-diabetic medication, Glyconorm 0.3 GM1 tablet, a combined formulation, should adhere to the prescribed dosage and timing. This medication, indicated for adult-onset type 2 diabetes, helps regulate blood glucose. Consistent daily intake, ideally with meals, is crucial for optimal therapeutic effect. Dosage adjustments are determined by your physician based on blood sugar monitoring. Discontinuing Glyconorm 0.3 GM1 without medical consultation risks elevated blood sugar, potentially leading to complications like nephropathy, retinopathy, neuropathy, and limb loss. Remember, this medicine complements a holistic diabetes management plan including diet, exercise, and weight management as directed by your doctor. Hypoglycemia (low blood sugar) is a common side effect, characterized by symptoms such as sweating, dizziness, headache, and tremors. Carry a fast-acting glucose source, like sugary snacks or juice, to counteract this. Alcohol consumption should be minimized due to its hypoglycemic potential. Additional possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, cephalalgia, edema, visual disturbances, bone fractures, and upper respiratory infections. Weight gain is also a possibility. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart conditions should be disclosed to your physician before initiating treatment. Pregnant or lactating individuals must consult their doctor. Regular blood glucose monitoring, along with periodic blood tests to assess blood cell counts and liver function, are essential components of therapy.

Uses of Voglow 0.3 GM1 Tablet

Managing type 2 diabetes

Major Benefits of Voglow 0.3 GM1 Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the entire tablet without chewing, crushing, or breaking it. Voglow 0.3 GM1 Tablets should be taken on an empty stomach.

Common Side effects of Voglow 0.3 GM1 Tablet:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Voglow 0.3 GM1 Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 0.3 GM1 Voglow tablet whole; do not crush, chew, or break it. Administer on an empty stomach.

How Voglow 0.3 GM1 Tablet works:

Each Voglow 0.3 GM1 tablet contains a triple-action formulation of antidiabetic medications.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Alcohol and Voglow 0.3 GM1 Tablets should not be taken together due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Voglow 0.3 GM1 tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescription. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Breastfeeding while taking Voglow 0.3 GM1 Tablets is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyUNSAFE

The use of Voglow 0.3 GM1 Tablets is likely unsafe for individuals with kidney impairment and should be avoided. Seek medical advice before use. Patients with severe kidney disease should not use Voglow 0.3 GM1 Tablets.

LiverLiverCAUTION

Patients with liver impairment should use Voglow 0.3 GM1 Tablets cautiously, potentially requiring dose modification. Consultation with a physician is advised. For those with mild to moderate liver disease, a low initial dose is typically prescribed; however, Voglow 0.3 GM1 Tablets are contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Voglow 0.3 GM1 Tablet :

Should you forget to take a Voglow 0.3 GM1 Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Voglow 0.3 GM1 Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Voglow 0.3 GM1 Tablet

Voglow 0.3 GM1 Tablet combines glimepiride, metformin, and voglibose to treat type 2 diabetes mellitus in adults. It helps control blood sugar when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas; metformin reduces liver glucose production and enhances insulin sensitivity; and voglibose, an alpha-glucosidase inhibitor, lowers post-meal blood sugar. This combination is unsuitable for type 1 diabetes.
Voglow 0.3 GM1 Tablet may cause common side effects including hypoglycemia, nausea, diarrhea, altered taste, flatulence, abdominal pain, headache, rash, and respiratory infection.
Voglow 0.3 GM1 Tablets are contraindicated in patients allergic to any ingredient. Avoid use in patients with moderate to severe kidney disease, inflammatory bowel disease, colonic ulcerations, or metabolic acidosis (including diabetic ketoacidosis).
Combining Voglow 0.3 GM1 Tablet and alcohol is unsafe. This combination may worsen low blood sugar and raise the risk of lactic acidosis.
Voglow 0.3 GM1 Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice for emergencies.
Store this medication in its original, tightly closed container, following the storage instructions on the packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Voglow 0.3 GM1 Tablet
100
MRP 122
18% off